Tilray Brands, Inc (TLRY)

$1.44

-0.03

(-2.04%)▲

Market is closed - opens 8 PM, 14 Nov 2024

Performance

  • $1.40
    $1.48
    $1.44
    downward going graph

    2.78%

    Downside

    Day's Volatility :5.08%

    Upside

    2.37%

    downward going graph
  • $1.36
    $2.97
    $1.44
    downward going graph

    5.56%

    Downside

    52 Weeks Volatility :54.21%

    Upside

    51.52%

    downward going graph

Returns

PeriodTilray Brands, IncSector (Health Care)Index (Russel 2000)
3 Months
-25.0%
-3.2%
0.0%
6 Months
-31.1%
1.9%
0.0%
1 Year
-16.76%
14.8%
0.0%
3 Years
-88.95%
9.7%
-26.7%

Highlights

Market Capitalization
1.3B
Book Value
$3.97
Earnings Per Share (EPS)
-0.28
Wall Street Target Price
2.24
Profit Margin
-26.18%
Operating Margin TTM
-14.69%
Return On Assets TTM
-1.4%
Return On Equity TTM
-5.84%
Revenue TTM
812.0M
Revenue Per Share TTM
1.03
Quarterly Revenue Growth YOY
13.100000000000001%
Gross Profit TTM
116.8M
EBITDA
31.1M
Diluted Eps TTM
-0.28
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.32
EPS Estimate Next Year
-0.1
EPS Estimate Current Quarter
-0.04
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Hold
    40%Buy
    59%Hold
    0
    0%Sell
Based on 22 Wall street analysts offering stock ratings for Tilray Brands, Inc(by analysts ranked 0 to 5 stars)
Based on 22 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
13
12
13
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 55.56%

Current $1.44
Target $2.24

Technicals Summary

Sell

Neutral

Buy

Tilray Brands, Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Tilray Brands, Inc
Tilray Brands, Inc
-9.43%
-31.1%
-16.76%
-88.95%
-93.91%
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
7.79%
-9.37%
11.68%
42.98%
14.24%
Haleon Plc Spon Ads
Haleon Plc Spon Ads
-8.61%
10.94%
13.11%
24.56%
24.56%
Zoetis Inc.
Zoetis Inc.
-8.1%
4.84%
2.54%
-18.06%
52.29%
Viatris Inc.
Viatris Inc.
14.14%
16.7%
41.0%
-6.47%
-20.44%
Catalent, Inc.
Catalent, Inc.
-2.47%
6.54%
66.48%
-53.86%
20.44%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Tilray Brands, Inc
Tilray Brands, Inc
6.93
NA
NA
-0.32
-0.06
-0.01
NA
3.97
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
33.47
33.47
0.3
4.01
0.16
0.12
NA
26.87
Haleon Plc Spon Ads
Haleon Plc Spon Ads
27.29
27.29
1.63
0.38
0.07
0.04
0.02
1.82
Zoetis Inc.
Zoetis Inc.
32.66
32.66
2.45
5.88
0.47
0.15
0.01
11.59
Viatris Inc.
Viatris Inc.
224.4
NA
0.08
2.67
-0.04
0.02
0.04
16.58
Catalent, Inc.
Catalent, Inc.
211.02
NA
2.96
0.2
-0.11
0.0
NA
19.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Tilray Brands, Inc
Tilray Brands, Inc
Hold
$1.3B
-93.91%
6.93
-26.18%
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
Buy
$12.7B
14.24%
33.47
17.21%
Haleon Plc Spon Ads
Haleon Plc Spon Ads
Buy
$42.5B
24.56%
27.29
10.75%
Zoetis Inc.
Zoetis Inc.
Buy
$79.9B
52.29%
32.66
26.55%
Viatris Inc.
Viatris Inc.
Hold
$15.4B
-20.44%
224.4
-5.87%
Catalent, Inc.
Catalent, Inc.
Hold
$10.8B
20.44%
211.02
-9.34%

Insights on Tilray Brands, Inc

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 229.88M → 200.04M (in $), with an average decrease of 13.0% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -31.74M → -39.16M (in $), with an average decrease of 23.4% per quarter

  • Vs CTLT

    In the last 1 year, Catalent, Inc. has given 66.5% return, outperforming this stock by 83.3%

  • Vs NBIX

    In the last 3 years, Tilray Brands, Inc has experienced a drawdown of -88.9%, however Neurocrine Biosciences Inc. resisted the overall trend and outperformed by 35.1%

Institutional Holdings

    Company Information

    tilray is a global leader in medical cannabis research and production dedicated to providing safe, consistent and reliable therapy to patients. we are the only gmp certified medical cannabis producer currently supplying products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers in australia, canada, the european union and the americas.

    Organization
    Tilray Brands, Inc
    Employees
    2650
    CEO
    Mr. Irwin David Simon
    Industry
    Health Technology

    FAQs